TreeWAS – Variant ID: rs10046257

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E10 Insulin-dependent diabetes mellitus	0.993	0.007	0.000
E10.3 With ophthalmic complications	0.988	0.012	0.000
E10.1 With ketoacidosis	0.979	0.021	0.000
E10.9 Without complications	0.952	0.048	0.000
E10.5 With peripheral circulatory complications	0.944	0.056	0.000
E10.4 With neurological complications	0.913	0.087	0.000
E10.8 With unspecified complications	0.858	0.142	0.000
E10.2 With renal complications	0.834	0.166	0.000
E10.0 With coma	0.808	0.192	0.000
E10.6 With other specified complications	0.748	0.252	0.000
E10.7 With multiple complications	0.712	0.288	0.000
E10-E14 Diabetes mellitus	0.158	0.842	0.000
E13 Other specified diabetes mellitus	0.114	0.886	0.000
E12 Malnutrition-related diabetes mellitus	0.113	0.887	0.000
E14 Unspecified diabetes mellitus	0.091	0.909	0.000
E13.9 Without complications	0.083	0.917	0.000
E13.8 With unspecified complications	0.082	0.918	0.000
E13.7 With multiple complications	0.082	0.918	0.000
E13.6 With other specified complications	0.082	0.918	0.000
E13.5 With peripheral circulatory complications	0.082	0.918	0.000
E13.4 With neurological complications	0.082	0.918	0.000
E13.3 With ophthalmic complications	0.082	0.918	0.000
E13.2 With renal complications	0.082	0.918	0.000
E13.1 With ketoacidosis	0.082	0.918	0.000
E13.0 With coma	0.082	0.918	0.000
E12.9 Without complications	0.081	0.919	0.000
E12.8 With unspecified complications	0.081	0.919	0.000
E12.7 With multiple complications	0.081	0.919	0.000
E12.6 With other specified complications	0.081	0.919	0.000
E12.5 With peripheral circulatory complications	0.081	0.919	0.000
E12.4 With neurological complications	0.081	0.919	0.000
E12.3 With ophthalmic complications	0.081	0.919	0.000
E12.2 With renal complications	0.081	0.919	0.000
E12.1 With ketoacidosis	0.081	0.919	0.000
E12.0 With coma	0.081	0.919	0.000
E14.8 With unspecified complications	0.081	0.919	0.000
K90.0 Coeliac disease	0.000	0.932	0.068
E14.7 With multiple complications	0.066	0.934	0.000
E14.6 With other specified complications	0.066	0.934	0.000
E14.5 With peripheral circulatory complications	0.066	0.934	0.000
E14.4 With neurological complications	0.066	0.934	0.000
E14.2 Withrenal complications	0.066	0.934	0.000
E14.1 With ketoacidosis	0.066	0.934	0.000
E14.0 With coma	0.066	0.934	0.000
E14.3 With ophthalmic complications	0.055	0.944	0.000
E11 Non-insulin-dependent diabetes mellitus	0.029	0.971	0.000
K90 Intestinal malabsorption	0.000	0.972	0.028
E11.5 With peripheral circulatory complications	0.024	0.976	0.000
E11.6 With other specified complications	0.021	0.978	0.000
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.000	0.979	0.021
K04.7 Periapical abscess without sinus	0.021	0.979	0.000
K90.9 Intestinal malabsorption, unspecified	0.000	0.979	0.021
E11.7 With multiple complications	0.021	0.979	0.000
K90.3 Pancreatic steatorrhoea	0.000	0.980	0.020
K90.2 Blind loop syndrome, not elsewhere classified	0.000	0.980	0.020
K90.1 Tropical sprue	0.000	0.980	0.020
E11.0 With coma	0.020	0.980	0.000
G95.2 Cord compression, unspecified	0.020	0.980	0.000
E11.1 With ketoacidosis	0.019	0.981	0.000
E11.3 With ophthalmic complications	0.019	0.981	0.000
E11.2 With renal complications	0.018	0.981	0.000
K04 Diseases of pulp and periapical tissues	0.018	0.982	0.000
E11.8 With unspecified complications	0.018	0.982	0.000
K90.8 Other intestinal malabsorption	0.000	0.983	0.017
K04.5 Chronic apical periodontitis	0.017	0.983	0.000
K04.6 Periapical abscess with sinus	0.016	0.984	0.000
Chapter IV Endocrine, nutritional and metabolic diseases	0.016	0.984	0.000
K04.0 Pulpitis	0.014	0.986	0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.014	0.986	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.014	0.986	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.014	0.986	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.013	0.987	0.000
K04.4 Acute apical periodontitis of pulpal origin	0.013	0.987	0.000
E16 Other disorders of pancreatic internal secretion	0.013	0.987	0.000
K04.3 Abnormal hard tissue formation in pulp	0.013	0.987	0.000
K04.2 Pulp degeneration	0.013	0.987	0.000
K04.1 Necrosis of pulp	0.013	0.987	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.013	0.987	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.013	0.987	0.000
E16.2 Hypoglycaemia, unspecified	0.013	0.987	0.000
K04.8 Radicular cyst	0.012	0.988	0.000
E40-E46 Malnutrition	0.012	0.988	0.000
T40.4 Other synthetic narcotics	0.012	0.988	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.012	0.988	0.000
K04.9 Other and unspecified diseases of pulp and periapical tissues	0.012	0.988	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.012	0.988	0.000
E20-E35 Disorders of other endocrine glands	0.012	0.988	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.012	0.988	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.012	0.988	0.000
T43.2 Other and unspecified antidepressants	0.011	0.989	0.000
E11.4 With neurological complications	0.011	0.989	0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.011	0.989	0.000
M65.34 Trigger finger-Hand	0.000	0.989	0.011
E50-E64 Other nutritional deficiencies	0.011	0.989	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.010	0.990	0.000
G95 Other diseases of spinal cord	0.010	0.990	0.000
E15 Nondiabetic hypoglycaemic coma	0.010	0.990	0.000
E24 Cushing's syndrome	0.010	0.990	0.000
E46 Unspecified protein-energy malnutrition	0.010	0.990	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.010	0.990	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.010	0.990	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.010	0.990	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.010	0.990	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.010	0.990	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.010	0.990	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.010	0.990	0.000
T44.0 Anticholinesterase agents	0.010	0.990	0.000
E25 Adrenogenital disorders	0.010	0.990	0.000
E21.0 Primary hyperparathyroidism	0.010	0.990	0.000
E16.9 Disorder of pancreatic internal secretion, unspecified	0.010	0.990	0.000
E16.8 Other specified disorders of pancreatic internal secretion	0.010	0.990	0.000
E16.4 Abnormal secretion of gastrin	0.010	0.990	0.000
E16.3 Increased secretion of glucagon	0.010	0.990	0.000
E16.1 Other hypoglycaemia	0.010	0.990	0.000
E26 Hyperaldosteronism	0.010	0.990	0.000
T40.6 Other and unspecified narcotics	0.010	0.990	0.000
E16.0 Drug-induced hypoglycaemia without coma	0.010	0.990	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.010	0.990	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.009	0.990	0.000
T43.9 Psychotropic drug, unspecified	0.009	0.990	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.009	0.990	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.009	0.990	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.009	0.990	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.009	0.990	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.009	0.990	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.009	0.990	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.009	0.990	0.000
E28 Ovarian dysfunction	0.009	0.991	0.000
T43.6 Psychostimulants with abuse potential	0.009	0.991	0.000
E21.5 Disorder of parathyroid gland, unspecified	0.009	0.991	0.000
E44 Protein-energy malnutrition of moderate and mild degree	0.009	0.991	0.000
E45 Retarded development following protein-energy malnutrition	0.009	0.991	0.000
E43 Unspecified severe protein-energy malnutrition	0.009	0.991	0.000
E42 Marasmic kwashiorkor	0.009	0.991	0.000
E41 Nutritional marasmus	0.009	0.991	0.000
E40 Kwashiorkor	0.009	0.991	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.009	0.991	0.000
T40.8 Lysergide [LSD]	0.009	0.991	0.000
T40.7 Cannabis (derivatives)	0.009	0.991	0.000
T40.5 Cocaine	0.009	0.991	0.000
T40.3 Methadone	0.009	0.991	0.000
T40.1 Heroin	0.009	0.991	0.000
T40.0 Opium	0.009	0.991	0.000
E61 Deficiency of other nutrient elements	0.009	0.991	0.000
E21.3 Hyperparathyroidism, unspecified	0.009	0.991	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.009	0.991	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.009	0.991	0.000
E32 Diseases of thymus	0.009	0.991	0.000
E31 Polyglandular dysfunction	0.009	0.991	0.000
E30 Disorders of puberty, not elsewhere classified	0.009	0.991	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.009	0.991	0.000
T36 Poisoning by systemic antibiotics	0.009	0.991	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.009	0.991	0.000
T39.4 Antirheumatics, not elsewhere classified	0.009	0.991	0.000
T39.2 Pyrazolone derivatives	0.009	0.991	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.008	0.991	0.000
E14.9 Without complications	0.008	0.991	0.000
E34 Other endocrine disorders	0.008	0.991	0.000
E24.9 Cushing's syndrome, unspecified	0.008	0.991	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.008	0.992	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.008	0.992	0.000
E20 Hypoparathyroidism	0.008	0.992	0.000
E21.4 Other specified disorders of parathyroid gland	0.008	0.992	0.000
E21.2 Other hyperparathyroidism	0.008	0.992	0.000
T45.5 Anticoagulants	0.008	0.992	0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.008	0.992	0.000
E24.2 Drug-induced Cushing's syndrome	0.008	0.992	0.000
E26.0 Primary hyperaldosteronism	0.008	0.992	0.000
E53 Deficiency of other B group vitamins	0.008	0.992	0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.008	0.992	0.000
G95.8 Other specified diseases of spinal cord	0.008	0.992	0.000
E64 Sequelae of malnutrition and other nutritional deficiencies	0.008	0.992	0.000
E63 Other nutritional deficiencies	0.008	0.992	0.000
E56 Other vitamin deficiencies	0.008	0.992	0.000
E51 Thiamine deficiency	0.008	0.992	0.000
E50 Vitamin A deficiency	0.008	0.992	0.000
E60 Dietary zinc deficiency	0.008	0.992	0.000
E59 Dietary selenium deficiency	0.008	0.992	0.000
E58 Dietary calcium deficiency	0.008	0.992	0.000
E54 Ascorbic acid deficiency	0.008	0.992	0.000
E52 Niacin deficiency [pellagra]	0.008	0.992	0.000
T38.1 Thyroid hormones and substitutes	0.008	0.992	0.000
E24.0 Pituitary-dependent Cushing's disease	0.008	0.992	0.000
E22 Hyperfunction of pituitary gland	0.008	0.992	0.000
E61.1 Iron deficiency	0.008	0.992	0.000
T40.2 Other opioids	0.008	0.992	0.000
E29 Testicular dysfunction	0.008	0.992	0.000
T38.9 Other and unspecified hormone antagonists	0.008	0.992	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.008	0.992	0.000
T38.7 Androgens and anabolic congeners	0.008	0.992	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.008	0.992	0.000
T38.5 Other oestrogens and progestogens	0.008	0.992	0.000
T38.4 Oral contraceptives	0.008	0.992	0.000
T38.2 Antithyroid drugs	0.008	0.992	0.000
T38.0 Glucocorticoids and synthetic analogues	0.008	0.992	0.000
E24.8 Other Cushing's syndrome	0.008	0.992	0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.008	0.992	0.000
E24.3 Ectopic ACTH syndrome	0.008	0.992	0.000
E24.1 Nelson's syndrome	0.008	0.992	0.000
G95.9 Disease of spinal cord, unspecified	0.008	0.992	0.000
T39.0 Salicylates	0.008	0.992	0.000
T42.1 Iminostilbenes	0.008	0.992	0.000
E65-E68 Obesity and other hyperalimentation	0.007	0.993	0.000
E25.9 Adrenogenital disorder, unspecified	0.007	0.993	0.000
E25.8 Other adrenogenital disorders	0.007	0.993	0.000
S22.30 Fracture of rib (closed)	0.007	0.993	0.000
E28.2 Polycystic ovarian syndrome	0.007	0.993	0.000
E26.9 Hyperaldosteronism, unspecified	0.007	0.993	0.000
E26.8 Other hyperaldosteronism	0.007	0.993	0.000
E26.1 Secondary hyperaldosteronism	0.007	0.993	0.000
E28.3 Primary ovarian failure	0.007	0.993	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.007	0.993	0.000
T39.1 4-Aminophenol derivatives	0.007	0.993	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.007	0.993	0.000
T45.8 Other primarily systemic and haematological agents	0.007	0.993	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.007	0.993	0.000
T45.6 Fibrinolysis-affecting drugs	0.007	0.993	0.000
T45.4 Iron and its compounds	0.007	0.993	0.000
T45.3 Enzymes, not elsewhere classified	0.007	0.993	0.000
T45.2 Vitamins, not elsewhere classified	0.007	0.993	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.007	0.993	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.007	0.993	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.007	0.993	0.000
T37.5 Antiviral drugs	0.007	0.993	0.000
T37.4 Anthelminthics	0.007	0.993	0.000
T37.3 Other antiprotozoal drugs	0.007	0.993	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.007	0.993	0.000
T37.1 Antimycobacterial drugs	0.007	0.993	0.000
T37.0 Sulphonamides	0.007	0.993	0.000
T41.5 Therapeutic gases	0.007	0.993	0.000
T41.4 Anaesthetic, unspecified	0.007	0.993	0.000
T41.3 Local anaesthetics	0.007	0.993	0.000
T41.2 Other and unspecified general anaesthetics	0.007	0.993	0.000
T41.1 Intravenous anaesthetics	0.007	0.993	0.000
T41.0 Inhaled anaesthetics	0.007	0.993	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.007	0.993	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.007	0.993	0.000
T48.5 Anti-common-cold drugs	0.007	0.993	0.000
T48.4 Expectorants	0.007	0.993	0.000
T48.3 Antitussives	0.007	0.993	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.007	0.993	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.007	0.993	0.000
T48.0 Oxytocic drugs	0.007	0.993	0.000
T49.9 Topical agent, unspecified	0.007	0.993	0.000
T49.8 Other topical agents	0.007	0.993	0.000
T49.7 Dental drugs, topically applied	0.007	0.993	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.007	0.993	0.000
T49.5 Ophthalmological drugs and preparations	0.007	0.993	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.007	0.993	0.000
T49.3 Emollients, demulcents and protectants	0.007	0.993	0.000
T49.2 Local astringents and local detergents	0.007	0.993	0.000
T49.1 Antipruritics	0.007	0.993	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.007	0.993	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.007	0.993	0.000
E28.9 Ovarian dysfunction, unspecified	0.007	0.993	0.000
E28.8 Other ovarian dysfunction	0.007	0.993	0.000
E28.1 Androgen excess	0.007	0.993	0.000
E28.0 Oestrogen excess	0.007	0.993	0.000
G95.0 Syringomyelia and syringobulbia	0.007	0.993	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.007	0.993	0.000
E44.1 Mild protein-energy malnutrition	0.007	0.993	0.000
E44.0 Moderate protein-energy malnutrition	0.007	0.993	0.000
E61.9 Deficiency of nutrient element, unspecified	0.007	0.993	0.000
E61.8 Deficiency of other specified nutrient elements	0.007	0.993	0.000
E61.7 Deficiency of multiple nutrient elements	0.007	0.993	0.000
E61.6 Vanadium deficiency	0.007	0.993	0.000
E61.5 Molybdenum deficiency	0.007	0.993	0.000
E61.4 Chromium deficiency	0.007	0.993	0.000
E61.3 Manganese deficiency	0.007	0.993	0.000
E61.2 Magnesium deficiency	0.007	0.993	0.000
E61.0 Copper deficiency	0.007	0.993	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.006	0.993	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.006	0.993	0.000
T47.7 Emetics	0.006	0.993	0.000
T47.6 Antidiarrhoeal drugs	0.006	0.993	0.000
T47.5 Digestants	0.006	0.993	0.000
T47.4 Other laxatives	0.006	0.993	0.000
T47.3 Saline and osmotic laxatives	0.006	0.993	0.000
T47.2 Stimulant laxatives	0.006	0.993	0.000
T47.0 Histamine H(2)-receptor antagonists	0.006	0.993	0.000
E30.9 Disorder of puberty, unspecified	0.006	0.993	0.000
E30.8 Other disorders of puberty	0.006	0.993	0.000
E30.1 Precocious puberty	0.006	0.993	0.000
E30.0 Delayed puberty	0.006	0.993	0.000
E31.9 Polyglandular dysfunction, unspecified	0.006	0.993	0.000
E31.8 Other polyglandular dysfunction	0.006	0.993	0.000
E31.1 Polyglandular hyperfunction	0.006	0.993	0.000
E31.0 Autoimmune polyglandular failure	0.006	0.993	0.000
E32.9 Disease of thymus, unspecified	0.006	0.993	0.000
E32.8 Other diseases of thymus	0.006	0.993	0.000
E32.1 Abscess of thymus	0.006	0.993	0.000
E32.0 Persistent hyperplasia of thymus	0.006	0.993	0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.006	0.993	0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.006	0.993	0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.006	0.993	0.000
T36.9 Systemic antibiotic, unspecified	0.006	0.993	0.000
T36.8 Other systemic antibiotics	0.006	0.993	0.000
T36.7 Antifungal antibiotics, systemically used	0.006	0.993	0.000
T36.6 Rifamycins	0.006	0.993	0.000
T36.5 Aminoglycosides	0.006	0.993	0.000
T36.4 Tetracyclines	0.006	0.993	0.000
T36.3 Macrolides	0.006	0.993	0.000
T36.2 Chloramphenicol group	0.006	0.993	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.006	0.993	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.007	0.993	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.007	0.993	0.000
T42.3 Barbiturates	0.007	0.993	0.000
T42.2 Succinimides and oxazolidinediones	0.007	0.993	0.000
T42.0 Hydantoin derivatives	0.007	0.993	0.000
G91 Hydrocephalus	0.007	0.993	0.000
G95.1 Vascular myelopathies	0.006	0.994	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.006	0.994	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.006	0.994	0.000
T46.7 Peripheral vasodilators	0.006	0.994	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.006	0.994	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.006	0.994	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.006	0.994	0.000
E34.9 Endocrine disorder, unspecified	0.006	0.994	0.000
E34.8 Other specified endocrine disorders	0.006	0.994	0.000
E34.5 Androgen resistance syndrome	0.006	0.994	0.000
E34.4 Constitutional tall stature	0.006	0.994	0.000
E34.3 Short stature, not elsewhere classified	0.006	0.994	0.000
E34.2 Ectopic hormone secretion, not elsewhere classified	0.006	0.994	0.000
E34.1 Other hypersecretion of intestinal hormones	0.006	0.994	0.000
T46.1 Calcium-channel blockers	0.006	0.994	0.000
E20.8 Other hypoparathyroidism	0.006	0.994	0.000
E20.1 Pseudohypoparathyroidism	0.006	0.994	0.000
E20.0 Idiopathic hypoparathyroidism	0.006	0.994	0.000
G91.9 Hydrocephalus, unspecified	0.006	0.994	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.006	0.994	0.000
G90-G99 Other disorders of the nervous system	0.006	0.994	0.000
E22.0 Acromegaly and pituitary gigantism	0.006	0.994	0.000
E55 Vitamin D deficiency	0.005	0.994	0.001
E53.9 Vitamin B deficiency, unspecified	0.006	0.994	0.000
E53.1 Pyridoxine deficiency	0.006	0.994	0.000
E53.0 Riboflavin deficiency	0.006	0.994	0.000
E50.9 Vitamin A deficiency, unspecified	0.006	0.994	0.000
E50.8 Other manifestations of vitamin A deficiency	0.006	0.994	0.000
E50.7 Other ocular manifestations of vitamin A deficiency	0.006	0.994	0.000
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea	0.006	0.994	0.000
E50.5 Vitamin A deficiency with night blindness	0.006	0.994	0.000
E50.4 Vitamin A deficiency with keratomalacia	0.006	0.994	0.000
E50.3 Vitamin A deficiency with corneal ulceration and xerosis	0.006	0.994	0.000
E50.2 Vitamin A deficiency with corneal xerosis	0.006	0.994	0.000
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis	0.006	0.994	0.000
E50.0 Vitamin A deficiency with conjunctival xerosis	0.006	0.994	0.000
E51.9 Thiamine deficiency, unspecified	0.006	0.994	0.000
E51.8 Other manifestations of thiamine deficiency	0.006	0.994	0.000
E51.2 Wernicke's encephalopathy	0.006	0.994	0.000
E51.1 Beriberi	0.006	0.994	0.000
E56.9 Vitamin deficiency, unspecified	0.006	0.994	0.000
E56.8 Deficiency of other vitamins	0.006	0.994	0.000
E56.1 Deficiency of vitamin K	0.006	0.994	0.000
E56.0 Deficiency of vitamin E	0.006	0.994	0.000
E63.9 Nutritional deficiency, unspecified	0.006	0.994	0.000
E63.8 Other specified nutritional deficiencies	0.006	0.994	0.000
E63.1 Imbalance of constituents of food intake	0.006	0.994	0.000
E63.0 Essential fatty acid [EFA] deficiency	0.006	0.994	0.000
E64.9 Sequelae of unspecified nutritional deficiency	0.006	0.994	0.000
E64.8 Sequelae of other nutritional deficiencies	0.006	0.994	0.000
E64.3 Sequelae of rickets	0.006	0.994	0.000
E64.2 Sequelae of vitamin C deficiency	0.006	0.994	0.000
E64.1 Sequelae of vitamin A deficiency	0.006	0.994	0.000
E64.0 Sequelae of protein-energy malnutrition	0.006	0.994	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.006	0.994	0.000
E53.8 Deficiency of other specified B group vitamins	0.006	0.994	0.000
E34.0 Carcinoid syndrome	0.006	0.994	0.000
T36.0 Penicillins	0.006	0.994	0.000
E27 Other disorders of adrenal gland	0.006	0.994	0.000
E22.9 Hyperfunction of pituitary gland, unspecified	0.006	0.994	0.000
E22.8 Other hyperfunction of pituitary gland	0.006	0.994	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.006	0.994	0.000
E29.9 Testicular dysfunction, unspecified	0.006	0.994	0.000
E29.8 Other testicular dysfunction	0.006	0.994	0.000
E29.0 Testicular hyperfunction	0.006	0.994	0.000
M65.3 Trigger finger	0.000	0.994	0.006
F42.9 Obsessive-compulsive disorder, unspecified	0.006	0.994	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.006	0.994	0.000
E22.1 Hyperprolactinaemia	0.006	0.994	0.000
G91.2 Normal-pressure hydrocephalus	0.006	0.994	0.000
E20.9 Hypoparathyroidism, unspecified	0.005	0.994	0.000
E23 Hypofunction and other disorders of pituitary gland	0.006	0.994	0.000
G91.1 Obstructive hydrocephalus	0.006	0.994	0.000
E67 Other hyperalimentation	0.005	0.994	0.000
E68 Sequelae of hyperalimentation	0.005	0.994	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.005	0.994	0.000
T50.8 Diagnostic agents	0.005	0.995	0.000
T50.7 Analeptics and opioid receptor antagonists	0.005	0.995	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.005	0.995	0.000
T50.5 Appetite depressants	0.005	0.995	0.000
T50.4 Drugs affecting uric acid metabolism	0.005	0.995	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.005	0.995	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.005	0.995	0.000
T50.1 Loop [high-ceiling] diuretics	0.005	0.995	0.000
T50.0 Mineralocorticoids and their antagonists	0.005	0.995	0.000
G90.0 Idiopathic peripheral autonomic neuropathy	0.005	0.995	0.000
E65 Localised adiposity	0.005	0.995	0.000
T45.0 Antiallergic and antiemetic drugs	0.005	0.995	0.000
M75.4 Impingement syndrome of shoulder	0.005	0.995	0.000
G90 Disorders of autonomic nervous system	0.005	0.995	0.000
G91.8 Other hydrocephalus	0.005	0.995	0.000
G91.3 Posttraumatic hydrocephalus, unspecified	0.005	0.995	0.000
G91.0 Communicating hydrocephalus	0.005	0.995	0.000
F41.9 Anxiety disorder, unspecified	0.005	0.995	0.000
E27.2 Addisonian crisis	0.005	0.995	0.000
S22.3 Fracture of rib	0.005	0.995	0.000
G94 Other disorders of brain in diseases classified elsewhere	0.005	0.995	0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.005	0.995	0.000
E29.1 Testicular hypofunction	0.005	0.995	0.000
E27.9 Disorder of adrenal gland, unspecified	0.004	0.995	0.000
G98 Other disorders of nervous system, not elsewhere classified	0.005	0.995	0.000
G92 Toxic encephalopathy	0.005	0.995	0.000
E55.0 Rickets, active	0.004	0.995	0.001
G96 Other disorders of central nervous system	0.005	0.995	0.000
E27.8 Other specified disorders of adrenal gland	0.004	0.995	0.000
F42 Obsessive-compulsive disorder	0.005	0.995	0.000
E27.5 Adrenomedullary hyperfunction	0.004	0.995	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.004	0.995	0.000
E27.0 Other adrenocortical overactivity	0.004	0.995	0.000
Z91.5 Personal history of self-harm	0.005	0.995	0.000
M65.39 Trigger finger-Site unspec	0.000	0.996	0.004
M65.38 Trigger finger-Other	0.000	0.996	0.004
M65.37 Trigger finger-Ankle/foot	0.000	0.996	0.004
M65.36 Trigger finger-Lower leg	0.000	0.996	0.004
M65.35 Trigger finger-Pelvic/thigh	0.000	0.996	0.004
M65.33 Trigger finger-Forearm	0.000	0.996	0.004
M65.32 Trigger finger-Upper arm	0.000	0.996	0.004
M65.31 Trigger finger-Shldr region	0.000	0.996	0.004
M65.30 Trigger finger-Mult sites	0.000	0.996	0.004
K83.8 Other specified diseases of biliary tract	0.000	0.996	0.004
G97 Postprocedural disorders of nervous system, not elsewhere classified	0.004	0.996	0.000
E23.7 Disorder of pituitary gland, unspecified	0.004	0.996	0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.004	0.996	0.000
E23.1 Drug-induced hypopituitarism	0.004	0.996	0.000
T42.4 Benzodiazepines	0.004	0.996	0.000
G61.0 Guillain-Barre syndrome	0.000	0.996	0.004
E67.8 Other specified hyperalimentation	0.004	0.996	0.000
E67.3 Hypervitaminosis D	0.004	0.996	0.000
E67.2 Megavitamin-B6 syndrome	0.004	0.996	0.000
E67.1 Hypercarotenaemia	0.004	0.996	0.000
E67.0 Hypervitaminosis A	0.004	0.996	0.000
H36.0 Diabetic retinopathy	0.004	0.996	0.000
S22.00 Fracture of thoracic vertebra (closed)	0.004	0.996	0.000
G90.8 Other disorders of autonomic nervous system	0.004	0.996	0.000
G90.4 Autonomic dysreflexia	0.004	0.996	0.000
G90.1 Familial dysautonomia [Riley-Day]	0.004	0.996	0.000
G94.2 Hydrocephalus in other diseases classified elsewhere	0.004	0.996	0.000
G96.1 Disorders of meninges, not elsewhere classified	0.004	0.996	0.000
E23.6 Other disorders of pituitary gland	0.004	0.996	0.000
I61.9 Intracerebral haemorrhage, unspecified	0.004	0.996	0.000
J81 Pulmonary oedema	0.004	0.996	0.000
S22.31 Fracture of rib (open)	0.004	0.996	0.000
G94.8 Other specified disorders of brain in diseases classified elsewhere	0.004	0.996	0.000
G94.1 Hydrocephalus in neoplastic disease	0.004	0.996	0.000
G94.0 Hydrocephalus in infectious and parasitic diseases classified elsewhere	0.004	0.996	0.000
G45.3 Amaurosis fugax	0.004	0.996	0.000
F41 Other anxiety disorders	0.004	0.996	0.000
G97.0 Cerebrospinal fluid leak from spinal puncture	0.004	0.996	0.000
G90.2 Horner's syndrome	0.004	0.996	0.000
G90.3 Multisystem degeneration	0.003	0.996	0.000
F40-F48 Neurotic, stress-related and somatoform disorders	0.004	0.996	0.000
G96.9 Disorder of central nervous system, unspecified	0.003	0.996	0.000
G96.8 Other specified disorders of central nervous system	0.003	0.996	0.000
G90.9 Disorder of autonomic nervous system, unspecified	0.003	0.996	0.000
S22.0 Fracture of thoracic vertebra	0.004	0.996	0.000
F42.8 Other obsessive-compulsive disorders	0.003	0.996	0.000
F42.2 Mixed obsessional thoughts and acts	0.003	0.996	0.000
F42.1 Predominantly compulsive acts [obsessional rituals]	0.003	0.996	0.000
F42.0 Predominantly obsessional thoughts or ruminations	0.003	0.996	0.000
F43.1 Posttraumatic stress disorder	0.004	0.996	0.000
E23.2 Diabetes insipidus	0.003	0.996	0.000
G99 Other disorders of nervous system in diseases classified elsewhere	0.004	0.996	0.000
G97.9 Postprocedural disorder of nervous system, unspecified	0.003	0.997	0.000
G97.2 Intracranial hypotension following ventricular shunting	0.003	0.997	0.000
F43 Reaction to severe stress, and adjustment disorders	0.003	0.997	0.000
F44 Dissociative [conversion] disorders	0.003	0.997	0.000
Z48.8 Other specified surgical follow-up care	0.000	0.997	0.003
E23.0 Hypopituitarism	0.003	0.997	0.000
K90-K93 Other diseases of the digestive system	0.000	0.997	0.003
E55.9 Vitamin D deficiency, unspecified	0.001	0.997	0.002
S22 Fracture of rib(s), sternum and thoracic spine	0.003	0.997	0.000
G97.1 Other reaction to spinal and lumbar puncture	0.003	0.997	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.003	0.997	0.000
M19.93 Arthrosis, unspecified (Forearm)	0.003	0.997	0.000
K22.4 Dyskinesia of oesophagus	0.003	0.997	0.000
F44.9 Dissociative [conversion] disorder, unspecified	0.003	0.997	0.000
M46.99 Inflammatory spondylopathy, unspecified (Site unspecified)	0.000	0.997	0.003
F41.8 Other specified anxiety disorders	0.003	0.997	0.000
F41.3 Other mixed anxiety disorders	0.003	0.997	0.000
F20.9 Schizophrenia, unspecified	0.000	0.997	0.003
F41.2 Mixed anxiety and depressive disorder	0.003	0.997	0.000
F43.0 Acute stress reaction	0.003	0.997	0.000
G97.8 Other postprocedural disorders of nervous system	0.003	0.997	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.002	0.997	0.001
F48 Other neurotic disorders	0.003	0.997	0.000
S22.01 Fracture of thoracic vertebra (open)	0.003	0.997	0.000
I12.0 Hypertensive renal disease with renal failure	0.003	0.997	0.000
M10.96 Gout, unspecified (Lower leg)	0.000	0.997	0.003
G96.0 Cerebrospinal fluid leak	0.003	0.997	0.000
K22.8 Other specified diseases of oesophagus	0.003	0.997	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations